Connect with us

National

AstraZeneca-Oxford vaccine prevents 70 per cent of COVID-19 cases, study shows – The Age

Oxford University researchers revealed a scientific breakthrough with the potential to end the pandemic.

Published

on

In another positive finding, the Oxford vaccine needs only to be refrigerated, unlike other candidates developed by drug companies Pfizer and Moderna, which must be kept at extremely cold temperatures.
Refrigeration will make it easier to transport and store globally, particularly in lower and middle-income countries. The Oxford candidate is also much cheaper.
“We have a vaccine for the world,” said Professor Andrew Pollard, the trial’s lead investigator.
“Our goal at the beginning was to make sure…

Click here to view the original article.